Press "Enter" to skip to content

FDA statement on approval of OTC Primatene Mist to treat mild asthma

FDA approves new version of OTC Primatene Mist inhaler to treat mild, intermittent asthma for people who have been diagnosed with asthma by their physician

Original source:

Also Read:   FDA warns public not to use unapproved or uncleared medical devices to help assess or diagnose a concussion